Phosphodiesterase type-5 (PDE5) inhibitors are widely prescribed for erectile dysfunction and exert their pharmacologic effects through augmentation of nitric oxide-cyclic guanosine monophosphate signaling, a pathway with important ocular vascular implications... ...
